BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

16589

0

VAISHALI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Vaishali Pharma performance

Today’s low

Today’s high

₹ 12.75 ₹ 13.12
₹ 12.79

52 week low

52 week high

₹ 10.30 ₹ 24.91
₹ 12.79

Open Price

₹ 12.79

Prev. Close

₹ 12.79

Volume (Shares)

453088.00

Total traded value

₹ 57.94

Upper Circuit

₹ 15.34

Lower Circuit

₹ 10.23

info

Vaishali Pharma Share Price Update

As of the latest trading session, Vaishali Pharma share price is currently at ₹ 12.87, which is up by ₹ 0.07 from its previous closing. Today, the stock has fluctuated between ₹ 12.75 and ₹ 13.12. Over the past year, Vaishali Pharma has achieved a return of -18.15 %. In the last month alone, the return has been -1.99 %. Read More...

Investment Returns

Over 1 Month -1.99% Over 3 Months 4.07% Over 6 Months -21.52% Over 1 Year -18.15%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Vaishali Pharma fundamentals


  • Market cap (Cr)

    137.10

  • P/E Ratio (TTM)

    159.50

  • Beta

    0.90

  • Book Value / share

    5.62

  • Return on equity

    1.73%

  • EPS (TTM)

    0.08

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -4.29

info icon alternate text
  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

info icon alternate text

Vaishali Pharma Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 32.25
Operating Expense 38.84
Net Profit -4.29
Net Profit Margin (%) -13.30
Earnings Per Share (EPS) -3.17
EBITDA -5.03
Effective Tax Rate (%) 23.39
Particulars DEC 2024 (Values in Cr)
Revenue 27.91
Operating Expense 27.05
Net Profit 1.44
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 0.98
EBITDA 2.43
Effective Tax Rate (%) 24.87
Particulars SEP 2024 (Values in Cr)
Revenue 20.79
Operating Expense 18.86
Net Profit 1.97
Net Profit Margin (%) 9.47
Earnings Per Share (EPS) 1.51
EBITDA 3.13
Effective Tax Rate (%) 25.09
Particulars JUN 2024 (Values in Cr)
Revenue 18.08
Operating Expense 16.24
Net Profit 1.70
Net Profit Margin (%) 9.40
Earnings Per Share (EPS) 1.48
EBITDA 2.77
Effective Tax Rate (%) 25.11
Particulars MAR 2024 (Values in Cr)
Revenue 32.40
Operating Expense 39.72
Net Profit -4.68
Net Profit Margin (%) -14.44
Earnings Per Share (EPS) -4.37
EBITDA -5.88
Effective Tax Rate (%) 26.94
Particulars MAR 2025 (Values in Cr)
Revenue 99.03
Operating Expense 101.00
Net Profit 0.82
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.31
EBITDA 3.30
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 86.28
Operating Expense 87.39
Net Profit 0.72
Net Profit Margin (%) 0.83
Earnings Per Share (EPS) 0.67
EBITDA 3.17
Effective Tax Rate (%) 22.58
Particulars MAR 2023 (Values in Cr)
Revenue 69.66
Operating Expense 63.05
Net Profit 6.60
Net Profit Margin (%) 9.47
Earnings Per Share (EPS) 6.26
EBITDA 11.36
Effective Tax Rate (%) 25.31
Particulars MAR 2022 (Values in Cr)
Revenue 75.82
Operating Expense 71.88
Net Profit 4.02
Net Profit Margin (%) 5.30
Earnings Per Share (EPS) 3.82
EBITDA 8.65
Effective Tax Rate (%) 29.66
Particulars MAR 2021 (Values in Cr)
Revenue 52.31
Operating Expense 54.18
Net Profit 1.05
Net Profit Margin (%) 2.00
Earnings Per Share (EPS) 0.99
EBITDA 4.43
Effective Tax Rate (%) 25.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 39.97
ROE % 1.73
ROCE % 5.71
Total Debt to Total Equity 0.34
EBITDA Margin 4.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 38.43
ROE % 19.73
ROCE % 21.59
Total Debt to Total Equity 0.53
EBITDA Margin 16.67
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.99
ROE % 16.48
ROCE % 18.70
Total Debt to Total Equity 0.79
EBITDA Margin 11.43
Particulars MAR 2021 (Values in Cr)
Book Value / Share 21.26
ROE % 4.79
ROCE % 10.23
Total Debt to Total Equity 0.80
EBITDA Margin 8.29
Particulars MAR 2020 (Values in Cr)
Book Value / Share 20.27
ROE % 0.14
ROCE % 6.84
Total Debt to Total Equity 0.80
EBITDA Margin 5.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 79.95
Total Liabilities 79.95
Total Equity 42.83
Share Outstanding 10719213
Price to Book Ratio 3.50
Return on Assets (%) 0.89
Return on Capital (%) 1.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.98
Total Assets 78.89
Total Liabilities 78.89
Total Equity 40.53
Share Outstanding 10546213
Price to Book Ratio 3.80
Return on Assets (%) 8.36
Return on Capital (%) 12.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.35
Total Assets 81.62
Total Liabilities 81.62
Total Equity 26.35
Share Outstanding 10546213
Price to Book Ratio 2.65
Return on Assets (%) 4.92
Return on Capital (%) 8.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 86.12
Total Liabilities 86.12
Total Equity 22.41
Share Outstanding 10546213
Price to Book Ratio 1.53
Return on Assets (%) 1.21
Return on Capital (%) 2.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 66.20
Total Liabilities 66.20
Total Equity 21.38
Share Outstanding 10546213
Price to Book Ratio 1.98
Return on Assets (%) 0.04
Return on Capital (%) 0.09
Particulars MAR 2024 (Values in Cr)
Net Income 0.92
Cash from Operations 3.08
Cash from Investing 1.20
Cash from Financing -1.41
Net change in Cash 0.59
Free Cash Flow 3.19
Particulars MAR 2023 (Values in Cr)
Net Income 8.84
Cash from Operations 2.64
Cash from Investing 0.28
Cash from Financing -1.73
Net change in Cash -0.37
Free Cash Flow 2.94
Particulars MAR 2022 (Values in Cr)
Net Income 5.72
Cash from Operations 2.14
Cash from Investing -0.84
Cash from Financing 0.41
Net change in Cash 0.88
Free Cash Flow 3.01
Particulars MAR 2021 (Values in Cr)
Net Income 1.40
Cash from Operations 2.07
Cash from Investing -0.11
Cash from Financing -1.81
Net change in Cash 0.08
Free Cash Flow 2.20
Particulars MAR 2020 (Values in Cr)
Net Income 0.07
Cash from Operations 3.94
Cash from Investing -0.01
Cash from Financing -3.13
Net change in Cash 0.06
Free Cash Flow 3.99
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.19 32.03 1.98 277.34 34.11 / 77.70
BLISS GVS PHARMA LTD 155.40 19.45 1.56 1638.62 105.05 / 184.95
CIPLA LTD 1491.80 23.42 3.86 120493.85 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 356.25 13.64 2.88 1048.48 189.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 3300.35 63.97 28.65 55909.92 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.19 92.79 5.71 277.34 34.11 / 77.70
AMRUTAJAN HEALTH LTD 717.40 40.81 6.35 2074.05 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9296.00 132.76 30.16 23240.00 6222.35 / 10653.05
BLISS GVS PHARMA LTD 155.40 23.76 1.54 1638.62 105.05 / 184.95

Vaishali Pharma Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
12.79 0.23 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 12.20
  • 26 Days 12.20
  • 10 Days 12.10
  • 50 Days 12.50
  • 12 Days 12.10
  • 100 Days 13.20
  • 20 Days 12.10
  • 200 Days 14.30
12.75 PIVOT

First Support

12.61

First Resistance

12.90

Second Support

12.46

Second Resistance

13.04

Third Support

12.32

Third Resistance

13.19

RSI

59.84

ADX

44.62

MACD

-0.14

Williams % R

-9.31

Commodity Channel Index (CCI)

89.57

Date

2025-07-09

Week

663615.00

Same Day

603561.00

Month

483772.00

1 Year

0.91

3 Year

0.58

Over 1 Month

-1.99%

down

Over 1 Year

-18.15%

down

Over 3 Months

4.07%

down

Over 3 Years

15.55%

down

Over 6 Months

-21.52%

down

Over 5 Years

20.80%

down

Vaishali Pharma shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
73.67%
Promoter Holdings
26.32%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Atul Arvindbhai Vasani 2.262023E7 (21.1%) Shareholding of Promoter and Promoter Group
Sapan Anil Shah 7553189.0 (7.05%) Public Shareholding
Nupur Anil Shah 5750410.0 (5.36%) Public Shareholding
Jagruti Atul Vasani 4799920.0 (4.48%) Shareholding of Promoter and Promoter Group
Nishant Pitti 3098173.0 (2.89%) Public Shareholding
Renu Pittie 2419000.0 (2.26%) Public Shareholding
Sawaca Business Machines Limited 1480000.0 (1.38%) Public Shareholding
Krishna Awtar Kabra 1332000.0 (1.24%) Public Shareholding
Bharti Kiritkumar Tolia 720000.0 (0.67%) Shareholding of Promoter and Promoter Group
Punita Kaushik Gandhi 39770.0 (0.04%) Shareholding of Promoter and Promoter Group
Vaishali A Vasani 35320.0 (0.03%) Shareholding of Promoter and Promoter Group
Priyanka Atul Vasani 10.0 (0.0%) Shareholding of Promoter and Promoter Group
Ajay Arvindbhai Vasani 10.0 (0.0%) Shareholding of Promoter and Promoter Group
Kevin Atul Vasani 10.0 (0.0%) Shareholding of Promoter and Promoter Group
Dewansh Ajay Vasani 10.0 (0.0%) Shareholding of Promoter and Promoter Group
Aneree Ajay Vasani 10.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Vaishali Pharma corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
18 Oct 2019 17 Oct 2019 3:5
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Vaishali Pharma Share Price

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.

Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products.

The Company has over 250 + formulation brands marketed in multiple countries; of which dossier is in CTD format along with its
respective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Company's synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients.

In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments & Medical Devices Directive. In addition, the Company has also been recognized by Government of India as 'One Star Export House' and holds a valid certificate for the same from the Director General of Foreign Trade in 2017.

In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.

Parent organization Indian Private
NSE symbol VAISHALI
Founded 2008
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vaishali Pharma Ltd?

Answer Field

Vaishali Pharma Ltd share price is for NSE ₹ 12.87 & for BSE ₹ 0.00 as on Jul 11 2025 10:28 AM.

What is the Market Cap of Vaishali Pharma Ltd Share?

Answer Field

The market cap of Vaishali Pharma Ltd for NSE ₹ 137.10 & for BSE ₹ 0.00 as on Jul 11 2025 10:28 AM.

What is the 52 Week High and Low of Vaishali Pharma Ltd?

Answer Field

The 52 Week High and Low of Vaishali Pharma Ltd for NSE is ₹ 24.91 and ₹ 10.30 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Vaishali Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -18.15%.

What is the P/E Ratio of Vaishali Pharma Ltd Share?

Answer Field

As on Jul 11 2025 10:28 AM the price-to-earnings (PE) ratio for Vaishali Pharma Ltd share is 159.50.

What is the PB ratio of Vaishali Pharma Ltd Share?

Answer Field

As on Jul 11 2025 10:28 AM, the price-to-book (PB) ratio for Vaishali Pharma Ltd share is 5.62.

How to Buy Vaishali Pharma Ltd Share?

Answer Field

You can trade in Vaishali Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vaishali Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Vaishali Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vaishali Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|